Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
McConville, M.
Brennan, G. P.
Flanagan, A.
Hanna, R. E. B.
Edgar, H. W. J.
Castillo, R.
Hernández-Campos, A.
and
Fairweather, I.
2009.
Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.
Parasitology Research,
Vol. 105,
Issue. 3,
p.
757.
Toner, E.
Brennan, G.P.
Hanna, R.E.B.
Edgar, H.W.
and
Fairweather, I.
2010.
Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
Veterinary Parasitology,
Vol. 174,
Issue. 3-4,
p.
218.
TONER, E.
BRENNAN, G. P.
McCONVERY, F.
MEANEY, M.
and
FAIRWEATHER, I.
2010.
A transmission electron microscope study on the route of entry of triclabendazole into the liver fluke,Fasciola hepatica.
Parasitology,
Vol. 137,
Issue. 5,
p.
855.
Hanna, R.E.B.
Edgar, H.W.J.
McConnell, S.
Toner, E.
McConville, M.
Brennan, G.P.
Devine, C.
Flanagan, A.
Halferty, L.
Meaney, M.
Shaw, L.
Moffett, D.
McCoy, M.
and
Fairweather, I.
2010.
Fasciola hepatica: Histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
Veterinary Parasitology,
Vol. 168,
Issue. 3-4,
p.
240.
Devine, Catherine
Brennan, Gerard P.
Lanusse, Carlos E.
Alvarez, Luis I.
Trudgett, Alan
Hoey, Elizabeth
and
Fairweather, Ian
2010.
Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.
Parasitology Research,
Vol. 106,
Issue. 6,
p.
1351.
McConville, Maeve
Hanna, Robert E. B.
Brennan, Gerard P.
McCoy, Maurice
Edgar, Hillary W. J.
McConnell, Shirley
Castillo, Rafael
Hernández-Campos, Alicia
and
Fairweather, Ian
2010.
Fasciola hepatica: disruption of spermatogenesis by the fasciolicide compound alpha.
Parasitology Research,
Vol. 106,
Issue. 2,
p.
311.
DEVINE, C.
BRENNAN, G. P.
LANUSSE, C. E.
ALVAREZ, L. I.
TRUDGETT, A.
HOEY, E.
and
FAIRWEATHER, I.
2011.
Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica.
Parasitology,
Vol. 138,
Issue. 2,
p.
224.
Fairweather, I.
2011.
Liver fluke isolates: a question of provenance.
Veterinary Parasitology,
Vol. 176,
Issue. 1,
p.
1.
Devine, C.
Brennan, G. P.
Lanusse, C. E.
Alvarez, L. I.
Trudgett, A.
Hoey, E.
and
Fairweather, I.
2011.
Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.
Parasitology Research,
Vol. 109,
Issue. 4,
p.
981.
Chatterji, Biswa Prasun
Jindal, Bhavya
Srivastava, Sanjeeva
and
Panda, Dulal
2011.
Microtubules as antifungal and antiparasitic drug targets.
Expert Opinion on Therapeutic Patents,
Vol. 21,
Issue. 2,
p.
167.
Devine, C.
Brennan, G. P.
Lanusse, C. E.
Alvarez, L. I.
Trudgett, A.
Hoey, E.
and
Fairweather, I.
2011.
Erratum to: Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.
Parasitology Research,
Vol. 109,
Issue. 4,
p.
1209.
McConville, M.
Hanna, R.E.B.
Brennan, G.P.
Edgar, H.W.J.
McConnell, S.
McCoy, M.
Castillo, R.
Hernández-Campos, A.
and
Fairweather, I.
2012.
Impact of compound alpha treatment in vivo on egg production by the liver fluke, Fasciola hepatica.
Veterinary Parasitology,
Vol. 187,
Issue. 1-2,
p.
183.
Rojo-Vázquez, F.A.
Meana, A.
Valcárcel, F.
and
Martínez-Valladares, M.
2012.
Update on trematode infections in sheep.
Veterinary Parasitology,
Vol. 189,
Issue. 1,
p.
15.
Devine, C.
Brennan, G.P.
Lanusse, C.E.
Alvarez, L.I.
Trudgett, A.
Hoey, E.
and
Fairweather, I.
2012.
Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole.
Veterinary Parasitology,
Vol. 184,
Issue. 1,
p.
37.
Savage, J.
Meaney, M.
Brennan, G.P.
Hoey, E.
Trudgett, A.
and
Fairweather, I.
2013.
Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil.
Experimental Parasitology,
Vol. 135,
Issue. 3,
p.
642.
Flores-Ramos, Miguel
Ibarra-Velarde, Froylán
Hernández-Campos, Alicia
Vera-Montenegro, Yolanda
Jung-Cook, Helgi
Cantó-Alarcón, Germinal J.
del Rivero, Lauro Misael
and
Castillo, Rafael
2014.
A highly water soluble benzimidazole derivative useful for the treatment of fasciolosis.
Bioorganic & Medicinal Chemistry Letters,
Vol. 24,
Issue. 24,
p.
5814.
Hanna, Robert
2015.
Fasciola hepatica: Histology of the Reproductive Organs and Differential Effects of Triclabendazole on Drug-Sensitive and Drug-Resistant Fluke Isolates and on Flukes from Selected Field Cases.
Pathogens,
Vol. 4,
Issue. 3,
p.
431.
P.A., Ahammed Shareef
and
S.M.A., Abidi
2019.
Immature Fasciola gigantica: Time-dependent ultrastructural changes following in vivo treatment with triclabendazole.
Acta Tropica,
Vol. 196,
Issue. ,
p.
15.